“…Excessive consumption of oxygen and vascular shutdown during PDT results in hypoxia, thus reducing the therapeutic efficacy and preventing the full therapeutic response. Moreover, solid tumors have regions of intrinsic hypoxia because of the compromised microcirculation and decreased perfusion. ,, Therefore, QDs can act as hydrogenase-type catalysts and convert hydrogen peroxide (H 2 O 2 ), which may be present in high concentration in tumors, into 3 O 2 . , QDs provide us the opportunity to use either as an individual sensitizer of 1 O 2 generation (via TET or charge transfer) ,,− or by linking to some other sensitizer acceptor molecules, ,,,, thus acting like versatile sensitizers for 1 O 2 generation (Table ). The size-dependent confinement of excitons ensures the photophysics of QDs to position them strategically and selectively precise to an absorption profile of a molecular acceptor for potential energy transfer via FRET or TTET processes. ,,,− , It is noteworthy that the QDs also present variable shape morphology such as spheres, wires, rods, and platelets coupled with modifiable surface chemistry by depositing different anionic- or cationic-rich inorganic materials or molecular surface ligands.…”